Brigitte Tardy

Saint-etienne-de-valoux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Optimizing Perioperative Management of Haemophilia B With rFIX-FP: Pharmacokinetic Validation of the Hemoptidose Tool.

Optimizing Perioperative Management of Haemophilia B With rFIX-FP: Pharmacokinetic Validation of the Hemoptidose Tool.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 26, 2026

Safety of von Willebrand factor substitution for neuraxial anesthesia in women with persistent von Willebrand deficiency at delivery.

Safety of von Willebrand factor substitution for neuraxial anesthesia in women with persistent von Willebrand deficiency at delivery.

Journal: Research and practice in thrombosis and haemostasis

Published: March 03, 2026

Rivaroxaban use during vitamin K1 therapy for rodenticide poisoning.

Rivaroxaban use during vitamin K1 therapy for rodenticide poisoning.

Journal: Research and practice in thrombosis and haemostasis

Published: November 08, 2025

Prevalence of hemophilia in women and girls in Burkina Faso.

Prevalence of hemophilia in women and girls in Burkina Faso.

Journal: Annales de biologie clinique

Published: June 04, 2025

F8 gene variants influence the response to desmopressin in hemophilia A carriers.

F8 gene variants influence the response to desmopressin in hemophilia A carriers.

Journal: Blood

Published: May 06, 2025

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST).

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST).

Journal: Thrombosis and haemostasis

Published: January 21, 2025

ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B.

ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B.

Journal: European journal of haematology

Published: September 23, 2024

A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis.

A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis.

Journal: Thrombosis and haemostasis

Published: February 09, 2023

Whole F9 gene sequencing identified deep intronic variations in genetically unresolved hemophilia B patients.

Whole F9 gene sequencing identified deep intronic variations in genetically unresolved hemophilia B patients.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 25, 2022

Reinvestigation of unidentified causative variants in FXI-deficient patients: Focus on gene segment deletions.

Reinvestigation of unidentified causative variants in FXI-deficient patients: Focus on gene segment deletions.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 29, 2022

Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis.

Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 13, 2021

Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia.

Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia.

Journal: Journal of clinical medicine

Published: March 18, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026